Colossal is a firm focused on bioscience and the de-extinction of species like the woolly mammoth and dodo bird.

In the case of the thylacine that's the fat-tailed dunnart, in the case of the dodo it's the Nicobar pigeon, and in the case of the mammoth that's every living elephant species. The combined data ...

For the mammoth, that animal is the Asian elephant. High-profile investors in the endeavor include “Lord of the Rings” director Peter Jackson, socialite Paris Hilton, former professional ...

Fifteen-year-old Asian elephant bull Luk Chai is the first of Melbourne Zoo’s nine elephants to make the journey to Werribee.

Colossal, now valued at $10.2 billion, has already sequenced a mammoth genome and found a way to produce elephant stem cells capable of giving rise to several different cell types — two ...

Colossal Biosciences is working to bring back species like the woolly mammoth using CRISPR-Cas9 technology. The project aims to restore lost biodivers ...

So what does the woolly mammoth have to do with it? Back to the elephant—or rather, mammoth—in the room. What does resurrecting a giant herbivore do for biodiversity? That’s why Colossal ...

Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it.

Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth.

In 2015, Church conducted the first genetic splicing of frozen mammoth DNA onto elephant genes, using a cutting-edge gene-editing technique known as CRISPR. However, he also gained prominence for ...

Co-founder and Chief Executive Officer Ben Lamm says the company is on track to produce a woolly mammoth calf born to a surrogate elephant mother by late 2028. Dallas-based Colossal Biosciences ...